Cardiac


  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott starts trial of Encantor transcatheter aortic valve

    The balloon-expandable system could complement Abbott’s existing self-expanding Navitor device.

    By • Nov. 20, 2026
  • Four clinicians with a robotic surgery system in an operating room.
    Image attribution tooltip
    Permission granted by Remedy Robotics
    Image attribution tooltip

    Remedy Robotics raises $62M; Capstan’s mitral replacement robot progresses

    Remedy plans a pivotal trial and has its sights on bringing to market a system for neurovascular intervention, while Capstan Medical performed the first U.S. transcatheter mitral valve replacement with its investigational robot.

    By • Nov. 18, 2026
  • Three components of Johnson & Johnson's Ottava robotic surgery system are displayed. Explore the Trendline➔
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott’s defibrillation lead lands FDA approval and CE mark

    The authorizations position Abbott to launch a purpose-built lead for left bundle branch area pacing in the U.S. and Europe.

    By • Nov. 12, 2026
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge hires president of acute care therapies

    Stacy Beske joins Getinge from Philips and will take over the role on Dec. 1.

    By • Nov. 10, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards bumps up sales forecast on TAVR strength in Q3

    Going forward, the heart valve maker expects procedure volumes to rise following positive study data and expanded Medicare reimbursement.

    By • Nov. 5, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development

    As part of the agreement, Blackstone may receive regulatory and commercial milestone payments, plus royalties on net sales. 

    By • Nov. 5, 2026
  • A doctor and patient in the cath lab.
    Image attribution tooltip
    Image Supply via Getty Images
    Image attribution tooltip

    3 takeaways from TCT 2026

    Edwards’ TAVR results in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study findings.

    By • Nov. 4, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott starts pivotal trial for mitral valve replacement device

    The study is testing a device that Abbott executives believe can expand the mitral valve market.

    By • Nov. 2, 2026
  • An image of an oval blue medical device.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott grows cardiac portfolio with Amplatzer approval for valve leaks

    The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient from another open-heart surgery.

    By • Oct. 29, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards wins FDA approval for tricuspid valve repair device

    Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.

    By • Oct. 23, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins CE mark for Vitalis portfolio of cardiac pacemakers

    The CE mark clears Medtronic to sell conduction system pacing therapy devices in Europe.

    By • Oct. 20, 2026
  • A modern architectural design building featuring a red-brick façade with large glass windows displays a prominent sign of the Food and Drug Administration.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Edwards recall of Sapien mitral delivery systems tied to 1 death

    Edwards is asking customers to return some of the delivery systems used with its Sapien M3 devices after receiving three reports of balloons bursting when inflated during the procedure.

    By • Oct. 16, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific names Joseph Fitzgerald as chief operating officer

    Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.

    By • Oct. 8, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic names Felicia Kurz as cardiac ablation VP, GM

    Kurz’s appointment comes as Medtronic enjoys strong growth in electrophysiology therapies thanks to demand for its pulsed field ablation devices.

    By • Oct. 7, 2026
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott gets FDA nod for updates to heart failure monitoring system

    Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.

    By • Oct. 7, 2026
  • A person wearing a white, round patch on their upper arm holds a phone.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    ARPA-H awards more than $100M to biosensor development projects

    Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.

    By • Oct. 5, 2026
  • Surgeons wearing blue gowns perform an operation.
    Image attribution tooltip
    Retrieved from Michigan Medicine on October 02, 2026
    Image attribution tooltip

    Edwards’ adjustable heart valve for children lands FDA approval

    The device could help young patients avoid multiple open-heart surgeries as they grow, FDA officials said.

    By • Oct. 2, 2026
  • A modern two-story commercial office building with a mix of gray and wood paneling on the exterior. Large glass windows dominate both floors, and the front entrance features the "Medtronic" logo above double glass doors. The surrounding area includes a few small shrubs and empty parking spaces in front.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtronic reveals cardiac mapping and ablation software clearances

    The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation market targeted by rivals Abbott, Boston Scientific and J&J.

    By • Oct. 1, 2026
  • Intuitive da Vinci robot surgeon
    Image attribution tooltip
    Courtesy of Intuitive
    Image attribution tooltip

    Intuitive expands push into cardiac market with CE mark

    After de-emphasizing heart surgery for decades due to limits with its earlier platforms, the surgical robot maker is eyeing the large market in cardiovascular disease treatment.

    By • Sept. 25, 2026
  • new cfo appointments dell, warner, qurate
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CVRx names John Landry as CFO

    Landry joins in the aftermath of an investor’s call for the sale of the heart failure device company.

    By • Sept. 23, 2026
  • A MedAlliance Selution balloon stent
    Image attribution tooltip
    Courtesy of MedAlliance
    Image attribution tooltip

    Cordis wins FDA approval for sirolimus-eluting balloon

    The approval gives physicians an alternative to uncoated balloons and Boston Scientific’s paclitaxel-coated device.

    By • Sept. 22, 2026
  • A portrait of Lara Barghout.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Recor Medical ex-CEO Lara Barghout joins Medtronic

    Barghout, who led Recor when it won FDA approval of the first renal denervation treatment for hypertension, is the new president of Medtronic’s Interventional Cardiology Therapies business.

    By • Sept. 16, 2026
  • an interior shot of johnson and Johnson corporate lobby featuring signage
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J sells Laminar LAA closure assets it bought 3 years ago

    The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success under dedicated ownership, a spokesperson said.

    By • Sept. 16, 2026
  • A piece of paper with the word "Medicare" emblazoned on a blue background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    CMS expands TAVR Medicare coverage to asymptomatic patients

    The Centers for Medicare and Medicaid Services’ policy update extends Medicare coverage to severe aortic stenosis patients without symptoms, a change that analysts said will especially benefit Edwards Lifesciences.

    By • Sept. 11, 2026
  • Heart
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    ARPA-H to award $62.7M for AI in cardiovascular care

    Companies including Tempus AI and Updoc are tasked with building an agentic AI system for managing heart failure.

    By • Sept. 11, 2026